Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (115)

View All

Latest Posts

About This Stock More About This Stock
3 Biotech Stocks With Strong Quantitative Drivers
Article By: Andres Cardenal
Wednesday, February 13, 2019 6:18 AM EST
Investing in biotech stocks can lead to massive gains when positioned in the right names in such a promising industry. However, picking the best biotech stocks is much easier said than done.
In this article: AMGN, BIIB, GILD
Read
5 Best Biotech Bets Likely To Outperform Estimates In Q4
Article By: Zacks Investment Research
Wednesday, January 23, 2019 2:06 PM EST
There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.
In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO
Read
Long Idea Highlights From 2018
Article By: David Trainer
Monday, January 21, 2019 12:00 PM EST
These are the Long Idea highlights from 2018.
In this article: NPK, OCLR, AMGN
Read
Thirteen Companies Boosting Distributions For Long-Term Shareholders
Article By: Dividend Growth Investor
Monday, December 17, 2018 1:16 PM EST
An increase that is well below the rate of dividend growth indicates caution, while an increase that is close to or higher than the average indicates optimism.
In this article: O, BEN, T, AMGN, ERIE, GGG, THG, PFE, ABT, D, UBA, WM, VTR
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!

$AMGN

Comments Status Updates
July 2017 Stock Considerations
Dick Kaplan • 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 1 of 1 comments